Address: 1036 Budapest,
Lajos u. 48-66, A. lépcsőház, 2. emelet. H-1036 Budapest,Hungary
Tel: 06-1-250-8371
Web: http://www.fresenius-kabi.hu/
Fresenius Kabi a pharmaceutical company specializing in the treatment of patients with severe and chronic.
The Fresenius Kabi Hungary in Fresenius SE & Co. KGaA, Fresenius Kabi division’s Hungarian subsidiary. activity of ours is the most severe and in ambulatory patients with volume therapy, parenteral and enteral nutrition, intravenous anesthesia, oncology, antibiotics, pain therapy, nephrology is involved. Our products are our own and through other wholesale supply to the users.
Volume Therapy
Enteral Nutrition
Parenteral nutrition
Oncology
Intravenous Anaesthesia
Pain Therapy
Nephrology dietetics
Oszteológia
Gastroenterology
Dr Miklós Kellermayer elaborates on his priorities to implement a more practical, experience-focused curriculum as the recently appointed Dean of the Faculty of Medicine of Semmelweis University. Dr Kellermayer goes…
Veronika Ferencz, general manager of Exeltis Hungary, gives an update on the recent activies and achievement of the affiliate since her last PharmaBoardroom interview in 2016. Furthermore, Ferencz goes on…
István Hodász, CEO of Egis Pharmaceuticals PLC, introduces the longstanding history of the company and its positioning as a leading manufacturer of value-added generics with a strong presence in the…
Prof. Éva Szökő, president of the Hungarian Society for Pharmaceutical Sciences (MGYT), shares her insights on the activities of the society, its collaboration with institutions and industry players in the…
Jānis Meikšāns, newly appointed general manager of Teva Hungary, speaks about his first few months in the country. Meikšāns goes on to elaborate on Hungary’s key positioning as a strategic…
Dr Mátyás Szentiványi, Director General of the National Institute of Pharmacy and Nutrition (OGYEI), introduces the administrative authority and specifies his strategy to be an increasingly collaborative and communicative body…
Dr. Péter Ofner, Former Director of the Gottsegen Hungarian Insititute of Cardiology, shares his insights on the cardiological capabilities of the institute, the epidemiological profile of the country, the collaborations…
Dr. György Blaskó, former President and Chairman of the Hungarian European Clinical Research Infrastructure Network, explains the role of the research network, the impact it has on the Hungarian clinical…
Dr. György Bagdy, professor and former vice rector at Semmelweis University, shares his insights on the longstanding history of pharmacology in Hungary, the key strengths of the country in the…
Hungarian national champion Egis and French Big Pharma Sanofi have both made recent big-ticket investments in new facilities in Hungary. Egis’ new manufacturing plant in Körmend and Sanofi’s new shared…
Dr. József Mandl, President of the Medical Research Council (ETT), discusses the role of the council, the research environment in Hungary, its relationship with the European Clinical Research Infrastructure Network…
Júlia Lipovecz, director of Swisscham Hungary, shares insights into the association and its activities to promote Swiss foreign investment in Hungary, the importance of local collaboration, and how its members…
See our Cookie Privacy Policy Here
